Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies
Ovarian cancer is the most lethal neoplasm of the female genital organs. Despite indisputable progress in the treatment of ovarian cancer, the problems of chemo-resistance and recurrent disease are the main obstacles for successful therapy. One of the main reasons for this is the presence of a speci...
Main Authors: | Jacek R Wilczyński, Miłosz Wilczyński, Edyta Paradowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/5/2496 |
Similar Items
-
Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC)
by: Jacek R. Wilczyński, et al.
Published: (2022-12-01) -
“DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies
by: Jacek R. Wilczyński, et al.
Published: (2023-06-01) -
Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors
by: Seema C. Parte, et al.
Published: (2018-08-01) -
Prediction of Chemoresistance—How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer
by: Jacek Wilczyński, et al.
Published: (2023-12-01) -
High-Grade Serous Ovarian Cancer—A Risk Factor Puzzle and Screening Fugitive
by: Jacek Wilczyński, et al.
Published: (2024-01-01)